This retrospective case series evaluated the effectiveness of the hedgehog pathway inhibitor vismodegib for advanced periocular basal cell carcinoma (BCC). Source: AAO
This study compared the efficacy of a fixed-dose netarsudil/latanoprost combination therapy versus individual monotherapies for open-angle glaucoma and ocular hypertension. Source: AAO
This cross-sectional study compared the diagnostic accuracy of a smartphone-based artificial intelligence system versus ophthalmologist judgement for retinopathy screening in patients with diabetes. Source: AAO
This week, Aerie Pharmaceuticals expands into the dry eye space, two ophthalmic drugs snag orphan drug designations and NEI researchers unveil an AI-based system to screen stem cell-derived retinal tissues. Source: AAO
The authors retrospectively examined the performance of recently revised diagnostic criteria for pseudotumor cerebri syndrome. Source: AAO
This study assessed whether short-term use of topical NSAIDs or steroid therapy affects the efficacy of selective laser trabeculoplasty (SLT). Source: AAO
A contact lens for slowing pediatric myopia progression has received the FDA’s approval, according to manufacturer CooperVision. Source: AAO
This phase 3 trial assessed the safety and efficacy of OTX-101, an aqueous nanomicellar formulation of cyclosporine 0.09% for dry eye disease. Source: AAO
This paper presents characteristics associated with adherence to annual diabetic eye exams in the United States. Source: AAO
This week, Regenxbio sues the FDA over holds on their clinical trials, a hiker finds 4 live worms her eye and rumors hint at Apple’s augmented reality ventures. Source: AAO